Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Free Cash Flow: 2010-2025

Historic Free Cash Flow for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to -$735,840.

  • Sunshine Biopharma's Free Cash Flow rose 60.73% to -$735,840 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year increase of 42.96%. This contributed to the annual value of -$14.2 million for FY2024, which is 60.19% down from last year.
  • As of Q3 2025, Sunshine Biopharma's Free Cash Flow stood at -$735,840, which was up 48.67% from -$1.4 million recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Free Cash Flow high stood at -$297,355 for Q1 2021, and its period low was -$5.6 million during Q2 2024.
  • In the last 3 years, Sunshine Biopharma's Free Cash Flow had a median value of -$1.9 million in 2024 and averaged -$2.4 million.
  • Per our database at Business Quant, Sunshine Biopharma's Free Cash Flow tumbled by 858.16% in 2021 and then soared by 74.18% in 2025.
  • Over the past 5 years, Sunshine Biopharma's Free Cash Flow (Quarterly) stood at -$312,113 in 2021, then crashed by 681.96% to -$2.4 million in 2022, then increased by 5.46% to -$2.3 million in 2023, then slumped by 52.31% to -$3.5 million in 2024, then soared by 60.73% to -$735,840 in 2025.
  • Its last three reported values are -$735,840 in Q3 2025, -$1.4 million for Q2 2025, and -$1.7 million during Q1 2025.